Search for: "MERRELL v. U.S."
Results 361 - 380
of 382
Sort by Relevance
|
Sort by Date
12 Jan 2008, 11:53 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), opened the door for multitudinous challenges to experts and their opinions; and Bell Atlantic Co. v. [read post]
17 Dec 2007, 4:14 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as "gatekeepers" concerning the admissibility of evidence - does not apply at the class certification stage. [read post]
30 Oct 2007, 11:28 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), to challenge the reliability of that testimony. [read post]
30 Oct 2007, 1:37 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
22 Oct 2007, 9:50 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
4 Oct 2007, 8:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Supreme Court first tried to evict "junk science," at least from the federal courts. [read post]
10 Sep 2007, 3:47 pm
Merrell Dow Pharm., 509 U.S. 579 (1993) Popper, Conjectures and Refutations (5th ed. 1989) Neil Feigenson, Brain Imaging and Courtroom Evidence (2006). [read post]
5 Sep 2007, 7:39 am
., No. 06-30378, 2006 U.S. [read post]
12 Jul 2007, 5:11 am
The case citation is Daubert v Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) A Daubert motion is a motion, raised before or during trial, to exclude the presentation of unqualified evidence to a jury. [read post]
5 May 2007, 1:32 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (”Daubert I”), on remand, 43 F.3d 1311 (9th Cir.) [read post]
13 Apr 2007, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Frye v. [read post]
12 Apr 2007, 1:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 (1993). [read post]
11 Apr 2007, 1:10 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKTorts'Merrell Dow' Higher Proof of Causation Is Not Required in Product Liability Suit In re: Ephedra Products Liability Litigation U.S. [read post]
10 Apr 2007, 1:18 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).] [read post]
7 Apr 2007, 6:04 am
Weber, 2006 U.S. [read post]
4 Apr 2007, 8:16 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Federal Rule of Evidence 702. [read post]
20 Mar 2007, 3:51 am
Merrell, 509 U.S. 579 (1993) [read post]
15 Mar 2007, 6:33 am
Thompson, 478 U.S. 804 (1986). [read post]
7 Feb 2007, 4:08 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as “gatekeepers” concerning the admissibility of evidence - does not apply at the class certification stage. [read post]
6 Feb 2007, 10:33 pm
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [read post]
